ZUG, Switzerland, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations addressing neuro-ophthalmic ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio It is interesting to look back at the ...
The best way to understand where neuro-ophthalmology is and where it is going, according to one subspecialist, is to compare it to the state of parasitology 50 to 60 years ago, and the effort at that ...
—A large data analysis found a significantly heightened relative risk of optic neuritis in NMOSD, MOGAD, and other inflammatory diseases, supporting prompt evaluation of visual complaints in these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback